Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02094014 · ClinicalTrials.gov registry record
Auditory Masking Effects on Speech Fluency in Aphasia and Apraxia of Speech
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 46
- Enrollment target
NCT02094014: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT02094014 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02094014 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
Impaired speech production is a major obstacle to full participation in life roles by stroke survivors with aphasia and apraxia of speech. The proposed study will demonstrate the short-term effects of auditory masking on speech disfluencies and identify individual factors that predict a positive response, enabling future work to develop auditory masking as a treatment adjuvant targeting long-term improvement in speech. Providing an additional treatment option for adults with aphasia and apraxia of speech will have the clear benefit of improving quality of life and allowing individuals to participate more actively in their health care decisions through improved communication.
Primary Outcome
Measured disfluency duration in sentences produced while listening to masking noise compared to speaking in quiet without noise.
Interventions
- BEHAVIORAL Normal Auditory Feedback
- BEHAVIORAL Masked Auditory Feedback
- BEHAVIORAL Altered Auditory Feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-12 |
What the finished NCT02094014 record still lists
NCT02094014 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 46 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Normal Auditory Feedback is the first listed.
NCT02094014 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02094014 about?
NCT02094014 is a clinical study titled "Auditory Masking Effects on Speech Fluency in Aphasia and Apraxia of Speech". Impaired speech production is a major obstacle to full participation in life roles by stroke survivors with aphasia and apraxia of speech. The proposed study will demonstrate the short-term effects of auditory masking on speech disfluencies and identify individual factors that predict a positive res...
What is the current status of trial NCT02094014?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2014-03. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02094014?
The interventions under investigation include: Normal Auditory Feedback (BEHAVIORAL), Masked Auditory Feedback (BEHAVIORAL), Altered Auditory Feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT02094014?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia